Document:

Addendum to the CCD Camera Manufacture and Supply Agreement

 Exhibit 10.2 
  
 [CONFIDENTIAL TREATMENT REQUESTED. CERTAIN PORTIONS OF 
 THIS AGREEMENT HAVE BEEN REDACTED AND SEPARATELY FILED 
 WITH THE SECURITIES
AND EXCHANGE COMMISSION.] 
  
 ADDENDUM

 TO 
 CCD CAMERA MANUFACTURE AND SUPPLY AGREEMENT 
  
 This Addendum (this “Addendum”) to CCD Camera Manufacture and Supply Agreement is made and entered into on this 20th day of April, 2005 by and
between Spectral Instruments, Inc., an Arizona corporation with offices located at 420 N Bonita Avenue, Tucson, Arizona 85745 (the “Seller”), and Xenogen Corporation, a Delaware corporation, with offices located at 860 Atlantic Avenue,
Alameda, California 94501 (the “Buyer”), with reference to the recitals of facts and intentions for the purpose of confirming the covenants hereinafter set forth. 
  
 RECITALS: 
  
 A. Seller and Buyer have executed that certain CCD Camera Manufacture and Supply Agreement dated April, 2003 (the
“Agreement”) regarding the sale and purchase of the Products, defined in Paragraph l(a) of the Agreement. 
  
 B. The initial eighteen (18) month term of the Agreement expired in October, 2004. Pursuant to the provisions of the Agreement, the term of the Agreement
was automatically extended for eighteen (18) months from the initial expiration date. 
  
 C. Seller and Buyer have executed this Addendum for the purpose of modifying and supplementing the Agreement upon and in accordance with the terms and conditions hereinafter set forth. 
  
 COVENANTS: 
  
 In light of the forgoing Recitals and in consideration of the Covenants
hereinafter set forth, the parties agree as follows: 
  
 1.
Defined Terms. All capitalized terms used in this Addendum, which are defined in the Agreement, shall have the same meaning when used herein. Capitalized terms not otherwise defined in this Addendum shall have the meaning provided for such
terms under the Agreement. 
  
 2. Extension Periods. The
automatic eighteen (18) month extension periods provided for under Paragraph 7.1 of the Agreement shall be changed to twelve (12) month extension periods. 
  
 3. Expiration Date of Initial Automatic Extension. The expiration date of the initial automatic extension of the Agreement, unless otherwise
extended pursuant to the provisions of the Agreement, shall be October, 2005. 
  
 4. Exclusivity (¶ 3). The following is added at the end of section 3: *** 
  
 *** CONFIDENTIAL TREATMENT REQUESTED 
  

 1 

 5. Purchases (¶ 4.1). The following is added at the end of the second sentence of Paragraph
4.1: 
  
 “; provided, however, if the term of the Agreement
shall be automatically extended pursuant to Paragraph 7.1, each Purchase Order shall cover a twelve (12) month period (the “Extension Term”) during the Extension Term.” 
  
 6. Price (¶ 4.5). Replace the word “each” in the second line of the first sentence of Paragraph 4.5,
with the words “the initial”. 
  
 7. Product Warranty
(¶ 4.11). Replace entire line (B) with: “for a period of *** after delivery to Buyer will meet the Specifications therefore and perform in accordance with such Specifications; except that for Series 600 cameras vacuum hold time between
customer serviceable refresh is only warranted for ***. For 800 Series cameras vacuum hold time will be warranted for ***.” 
  
 8. New Product; Pricing. Seller’s invoice price for the 600 Series CCD Camera (the “600 Series”) is modified. In addition, the 800
Series CCD Camera (the “800 Series”), is added as an additional Product under the Agreement. Seller’s invoice price for the 600 Series and 800 Series during the Extension Term shall be as follows: 
  

					
	 Quantity    

	  	600 Series Prices

	  	800 Series Prices

  
 *** 
  
 9. Term (¶ 17.1). Replace “eighteen (18)” in the second
sentence of Paragraph 7.1 with “twelve (12)”. 
  
 10.
Schedule A – Products. Add the following as a new number two (2) to Schedule A: 
  
 “2. 800 Series CCD Camera head with enclosed power supply.” 
  
 11. Schedule B – Specifications. Add the following Specifications for 800 Series: 
  
 *** 
  
 *** CONFIDENTIAL TREATMENT REQUESTED 
  

 2 

 *** 
  
 *** CONFIDENTIAL TREATMENT REQUESTED 
  

 3 

 *** 
  
 12. Conflict. In the event of any conflict between or ambiguity resulting from the terms and provisions of this Addendum and the terms and
provisions of the Agreement, the terms and provisions of this Addendum shall be governing and shall control. 
  
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
  
 *** CONFIDENTIAL TREATMENT REQUESTED 
  

 4 

 IN WITNESS WHEREOF, the parties have executed this Addendum as of the date first above written. 
  

							
	 Spectral Instruments, Inc
 an Arizona
Corporation
	  	 Xenogen Corporation
 a Delaware
Corporation

				
	By:	 	 /s/ KEITH COPELAND

	  	By:	 	 /s/ WILLIAM A. ALBRIGHT, JR.

	Its:	 	CEO	  	Its:	 	CFO
	Date	 	4/20/05	  	Date:	 	22 April 2005

  

 5First Supplemental Indenture, dated as of May 4, 2005

 EXHIBIT 4.1 
  

First Supplemental Indenture (this “Supplemental Indenture”), dated as of May 4, 2005, between Impac Mortgage Holdings, Inc., a
Maryland corporation (the “Company”), and JPMorgan Chase National Bank, National Association, a national banking association, as Trustee (in such capacity, the “Trustee”). Capitalized terms used herein and not
defined shall have the meanings given to them in the Indenture (as defined below). 
  
 RECITALS 
  
 WHEREAS, the Company
and the Trustee have heretofore executed and delivered a junior subordinated indenture (the “Indenture”), dated as of April 1, 2005; 
  
 WHEREAS, Section 6(l) of the Purchase Agreement has been amended so that the Company will pay to the Trustee the whole amount due and payable on the
Securities for principal and interest and, in addition thereto, all amounts owing to the Trustee under Section 6.6 of the Indenture (collectively, the “Payment”) on or before May 23, 2005 if the Company does not (a) provide
to the Purchaser audited financial statements audited by KPMG LLP in form and substance reasonably satisfactory to the Purchaser in all material respects for the fiscal year ended December 31, 2004 or (b)
certify to the Purchaser that it is in full compliance under the Sarbanes-Oxley Act of 2002 (the “Covenant”), by no later than May 20, 2005; 
  
 WHEREAS, the parties to the Indenture desire to hereby amend Section 5.1(g) of the Indenture to reflect such amendment to the Purchase Agreement;

  
 WHEREAS, Section 9.2 of the Indenture, permit, with the
consent of Holders of not less than a majority in aggregate principal amount of the Outstanding Securities, by Act of said Holders, the Company and the Trustee the execution of supplemental indentures changing in any manner provisions of the
Indenture. 
  
 WHEREAS, pursuant to Section 9.2 of the Indenture,
each of the Company, the Trustee and JPMorgan Chase Bank, National Association, not in its individual capacity, but solely as Property Trustee for Impac Capital Trust #1, as Holder of 100% in aggregate principal amount of the Outstanding Securities,
wish to hereby consent to the execution of this supplemental indenture. 
  
 NOW THEREFORE, this First Supplemental Indenture Witnessesth: 
  
 For and in consideration of the foregoing, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders of the Securities as follows: 
  
 1. Amendment of Section 5.1(g) of the Indenture. Section 5.1(g) of the Indenture is hereby deleted in its entirety
and replaced with the following: 
  
 “(g) default of the
obligation of the Company set forth under Section 6(l) of the Purchase Agreement. For the avoidance of doubt, the Company acknowledges that the failure to pay to the Trustee the whole amount due and payable on the Securities for principal and
interest and, in addition thereto, all amounts owing the Trustee under Section 6.6 on or before May 23, 2005 if the Company does not a) provide audited financials statements audited by KPMG LLP in form and substance reasonably 
  

 1 

 satisfactory to the Purchaser in all material respects for the fiscal year ended December 31, 2004 or b)
certify to the Purchaser that it is in full compliance under the Sarbanes-Oxley Act of 2002, by May 20, 2005 will result in an Event of Default without any right to a written notice or cure period of the default.” 
  
 2. Consent. Pursuant to Section 9.2 of the Indenture, each of the
Company, the Trustee and JPMorgan Chase Bank, National Association, not in its individual capacity, but solely as Property Trustee for Impac Capital Trust #1, as Holder of 100% in aggregate principal amount of the Outstanding Securities, hereby
consents to the execution of this supplemental indenture. 
  
 3.
Miscellaneous. Sections 1.7 through 1.13 of the Indenture are herein incorporated by this reference, including, but not limited to, the sections regarding Governing Law. 
  
 * * * * 
  
 This instrument may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, but all such counterparts
shall together constitute but one and the same instrument. 
  
 * *
* * 
  

 2 

 IN WITNESS WHEREOF, the parties hereto have caused this First Supplemental Indenture to be duly executed,
all as of the date first above written. 
  

			
	IMPAC MORTGAGE HOLDINGS, INC.
		
	By:	 	/s/ Richard J. Johnson
	 	 	Name: Richard J. Johnson
	 	 	Title: Executive Vice President and Chief Financial Officer
	
	JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, as Trustee
		
	By:	 	/s/ Maria D. Calzado
	 	 	Name: Maria D. Calzado
	 	 	Title: Vice President
	
	JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, not in its individual capacity, but solely as Property Trustee for Impac Capital Trust #1
		
	By:	 	/s/ Maria D. Calzado
	 	 	Name: Maria D. Calzado
	 	 	Title: Vice President

  

 3Daniel S. McCrary Employment Letter Agreement

 EXHIBIT 10.89 
  
 [LETTERHEAD OF PATH 1] 
  
 January 12, 2005 
  
 Mr. Dan McCrary 
 60 Lorelei Lane 
 Menlo Park, CA 94025 
  
 Dear Dan, 
  
 I have enjoyed talking to you about joining the Path 1 team as Vice President of Marketing. I
am delighted to offer you this position as more fully set forth below: 
  

					
	 	 	 Position:
	  	Vice President of Marketing
			
	 	 	 Reporting to:
	  	John R. Zavoli, President & CEO
			
	 	 	 Classification:
	  	Exempt
			
	 	 	 Base Annual Salary:
	  	$165,000.00
			
	 	 	 Relocation Assistance:
	  	For a period of up to six months, you will receive a temporary living allowance totaling $8,000.00, payable semi-monthly with our normal payroll. This allowance shall be subject to all
applicable income and employment tax withholding.
			
	 	 	 	  	The company presently has no plans to relocate you and your family. However, should we mutually agree at a later time to relocate you, we will negotiate and agree on relocation assistance, if
any, toward the relocation.
			
	 	 	 Stock Options/
 Restricted Stock
	  	Subject to Board approval, stock options on 25,000 shares of Common Stock with an exercise price at fair market value on the date of grant, vesting in sixteen equal quarterly installments
over four (4) years in accordance with the company’s 2000 or 2004 Stock Option/Stock Issuance Plans.
			
	 	 	 	  	Subject to Board approval, 20,000 restricted shares pursuant to the 2000 or 2004 Stock Option/Stock Issuance Plans. The restricted stock shall vest over two (2) years, 50% cliff vest after
one (1) year of service, the balance ratably over each successive quarter.
			
	 	 	 Severance Agreement:
	  	Three (3) months severance in the form of salary & benefit continuation in case of termination for any reason other than for cause, effective after ninety (90) days of employment. Subject
to this severance arrangement, you shall be an “at-will” employee and your employment can be terminated at any time by Path 1.
			
	 	 	 Start Date:
	  	January     , 2005
			
	 	 	 Offer Expiration Date:
	  	January 20, 2005

  

 1 of 2 

 As a condition of employment, you must sign Path 1 Network Technologies’ Proprietary Information and Invention
Agreement on your first day of employment. This offer is also subject to satisfactory background check and evidence of your entitlement to work in the United States. 
  
 We offer a comprehensive benefits package, including company paid medical, dental, vision, Life and LTD. We provide 3 weeks of Paid Time
Off, as well as a holiday schedule that includes at least 11 assigned or floating holidays. We also offer a 401(k) plan and a Flexible Spending Plan. 
  
 This written offer of employment contains our complete offer. Any representations, whether written or oral, not contained in this letter are expressly cancelled and
superseded by this offer. 
  
 Dan, as I mentioned previously, I am very excited to
have you join our company at this very exciting time. I believe you can make a significant contribution. 
  
 Please sign and date the copy of this letter and return it to my attention. If you have any questions, please do not hesitate to contact me. 
  
 Sincerely, 
  
 John R. Zavoli 
 President and CEO 
  
  
  
 I understand that employment with Path 1 Network Technologies Inc. is “at will”, and not for a specified term, and is at the mutual consent of the employee and
the company. Accordingly, either the employee or the company can terminate the employment relationship at will, with or without cause, at any time. My signature below memorializes my full understanding and acceptance of this offer of employment.

  
 Approved and Accepted 
  

							
	 	  	 	 	 	  	 
	                Name	  	 	 	Date	  	 

  

 2 of 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]